Protective effects of cerebrolysin against chemotherapy (carmustine) induced cognitive impairment in Albino mice

References

• Abdel-Salam, O.M., et al., 2018. Cerebrolysin attenuates oxidative stress and neurodegeneration in acute malathion toxicity in the rat. Global Drugs and Therapeutics, 3 (4), 1–6.
   Google Scholar
• Aleynik, A. and Rameshwar, P., 2015. Stem cell therapy for brain tumors. International Journal of Translational Science, 2015 (1), 67–106.
   Google Scholar
• Areeb, M.Z., 2020. The role of receptor tyrosine kinases in mediating glioblastoma resistance to radiotherapy and temozolomide (Doctoral dissertation). The Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne.
   Google Scholar
• Brainin, M., 2018. Cerebrolysin: a multi-target drug for recovery after stroke. Expert Review of Neurotherapeutics, 18 (8), 681–687.
   PubMed Web of Science ®Google Scholar
• Cacabelos, R., et al., 2016. Novel therapeutic strategies for dementia. CNS & Neurological Disorders Drug Targets, 15 (2), 141–241.
   PubMed Web of Science ®Google Scholar
• Chen, N., Cochrane Dementia and Cognitive Improvement Group., et al., 2013. Cerebrolysin for vascular dementia. Cochrane Database of Systematic Reviews, 11, CD008900.
   Google Scholar
• Cohen, E.J., et al., 2017. Neural plasticity and network remodeling: from concepts to pathology. Neuroscience, 344, 326–345.
   PubMed Web of Science ®Google Scholar
• Dietrich, J., 2016. Cancer, chemotherapy and cognitive dysfunction. US Neurology, 12 (01), 43–45.
   Google Scholar
• Ellman, G.L., 1959. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics, 82 (1), 70–77.
   PubMed Web of Science ®Google Scholar
• Ellman, G.L., et al., 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7 (2), 88–95.
   PubMed Web of Science ®Google Scholar
• Gavrilova, S.I. and Alvarez, A., 2021. Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimerss disease: 30 years of clinical use. Medicinal Research Reviews, 41 (5), 2775–2803.
   PubMed Web of Science ®Google Scholar
• Green, L.C., et al., 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical Biochemistry, 126 (1), 131–138.
   PubMed Web of Science ®Google Scholar
• Jansen, C.E., et al., 2011. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Supportive Care in Cancer, 19 (10), 1647–1656.
   PubMed Web of Science ®Google Scholar
• Kotb, M.G., et al., 2019. Chemotherapy-induced cognitive impairment in hematological malignancies. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 55 (1), 1–8.
   PubMedGoogle Scholar
• Kraeuter, A.K., Guest, P.C., and Sarnyai, Z., 2019. The Y-Maze for assessment of spatial working and reference memory in mice. In: Pre-clinical models. New York, NY: Humana Press, 105–111.
   Google Scholar
• Kumar, A., Dogra, S., and Prakash, A., 2009. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: possible behavioral and biochemical alterations in rats. Behavioural Brain Research, 205 (2), 384–390.
   PubMed Web of Science ®Google Scholar
• Lasley, S.M. and Gilbert, M.E., 2002. Rat hippocampal glutamate and GABA release exhibit biphasic effects as a function of chronic lead exposure level. Toxicological Sciences, 66 (1), 139–147.
   PubMed Web of Science ®Google Scholar
• Lin, Y.L., et al., 2020. Encapsulated n-butylidenephthalide efficiently crosses the blood-brain barrier and suppresses growth of glioblastoma. International Journal of Nanomedicine, 15, 749–760.
   PubMed Web of Science ®Google Scholar
• Lomeli, N., et al., 2017. Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats. Free Radical Biology & Medicine, 102, 274–286.
   PubMed Web of Science ®Google Scholar
• Luhmann, H.J., 2016. Models of cortical malformation-chemical and physical. Journal of Neuroscience Methods, 260, 62–72.
   PubMed Web of Science ®Google Scholar
• Masliah, E., et al., 1999. Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice. Pharmacology Biochemistry and Behavior, 62 (2), 239–245.
   PubMed Web of Science ®Google Scholar
• Pondugula, S.R., et al., 2020. Oroxylum indicum extract prevents chemotherapy‐induced cognitive impairment in mice. The FASEB Journal, 34 (S1), 1–1.
   Google Scholar
• Ren, X., Clair, D.K.S., and Butterfield, D.A., 2017. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment. Pharmacological Research, 117, 267–273.
   PubMed Web of Science ®Google Scholar
• Requejo, C., et al., 2018. Nanodelivery of cerebrolysin and rearing in enriched environment induce neuroprotective effects in a preclinical rat model of Parkinson's disease. Molecular Neurobiology, 55 (1), 286–299.
   PubMed Web of Science ®Google Scholar
• Salas-Ramirez, K.Y., Bagnall, C., Frias, L., Abdali, S.A., Ahles, T.A., and Hubbard, K., 2015. Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways. Behavioural Brain Research, 292, 133–141.
   Google Scholar
• Samal, J., Rebelo, A.L., and Pandit, A., 2019. A window into the brain: tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders. Advanced Drug Delivery Reviews, 148, 68–145.
   PubMed Web of Science ®Google Scholar
• Saykin, A.J., Ahles, T.A., and McDonald, B.C., 2003. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Seminars in Clinical Neuropsychiatry, 4, 201–216.
   Google Scholar
• Schoenfeld, R., et al., 2017. Variants of the Morris water maze task to comparatively assess human and rodent place navigation. Neurobiology of Learning and Memory, 139, 117–127.
   PubMed Web of Science ®Google Scholar
• Shah, D., et al., 2019. Acquisition of spatial search strategies and reversal learning in the Morris water maze depend on disparate brain functional connectivity in mice. Cerebral Cortex, 29 (11), 4519–4529.
   PubMed Web of Science ®Google Scholar
• Shi, D.D., et al., 2019. Ginsenoside Rg1 prevents chemotherapy-induced cognitive impairment: associations with microglia-mediated cytokines, neuroinflammation, and neuroplasticity. Molecular Neurobiology, 56 (8), 5626–5642.
   PubMed Web of Science ®Google Scholar
• Singh, S. and Kumar, P., 2017. Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats. Inflammopharmacology, 25 (1), 69–79.
   PubMed Web of Science ®Google Scholar
• Solari, N. and Hangya, B., 2018. Cholinergic modulation of spatial learning, memory and navigation. The European Journal of Neuroscience, 48 (5), 2199–2230.
   PubMed Web of Science ®Google Scholar
• Wazqar, D.Y., 2019. Cognitive dysfunction and its predictors in adult patients with cancer receiving chemotherapy: a cross-sectional correlational study. Journal of Nursing Research, 27 (6), e56.
   Web of Science ®Google Scholar
• Wefel, J.S., et al., 2015. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. A Cancer Journal for Clinicians, 65 (2), 123–138.
   PubMed Web of Science ®Google Scholar
• Wills, E., 1966. Mechanisms of lipid peroxide formation in animal tissues. The Biochemical Journal, 99 (3), 667–676.
   PubMed Web of Science ®Google Scholar
• Ziganshina, L.E., Abakumova, T., and Hoyle, C.H., 2020. Cerebrolysin for acute ischaemic stroke. Cochrane Database of Systematic Reviews, 7, 1–54.
   Google Scholar